NCT07128849 Effect of Phase I Cardiac Rehab With or Without Upper Limb Cycle Ergometer
| NCT ID | NCT07128849 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | CAD |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-07-17 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-07-17 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the effects of an upper limb cycle ergometer in phase I CABG patients. This will likely enhance various outcomes such as quality of life, dyspnea, functional outcome measure, cardiovascular parameters, and upper limb mobility. If utilized, the arm ergometer may contribute to improve upper limb strength and endurance. This could result in improving upper limb range of motion and reducing the risk of adhesive capsulitis. This study will positively impact society by reducing morbidity and mortality rates, healthcare costs and ultimately improves patient care.
Eligibility Criteria
Inclusion Criteria: * Planned CABG patients * 40-65 years * Both male and female * Hemodynamic stable patients * Post extubation Exclusion Criteria: * Patients suffering from pulmonary diseases and thyroid disorders * Mechanical ventilation more than 24 hr * Mean arterial pressure i.e, \< 60 mmHg or \> 140 mmHg and heart rate not more than 120bpm * Having an orthopedic condition that makes the use of upper and lower extremity impossible. * Who have neurological impairment influencing breathing rate and heart rate. * Who required the implantation of an intra-aortic balloon during surgery * Who experienced postoperative complications such as pulmonary embolism
Contact & Investigator
Iram Nawaz, Mphill
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT07128849 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying CAD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07128849 currently recruiting?
Yes, NCT07128849 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT07128849 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07128849 clinical trial?
NCT07128849 is sponsored by Riphah International University. The principal investigator is Iram Nawaz, Mphill at Riphah International University. The trial plans to enroll 44 participants.